Tag Archives: Australian Pharmaceutical Industries

NPSA welcomes CSO news

The National Pharmaceutical Services Association (NPSA) has welcomed the recent Federal Government announcement of the reappointment of its four member organisations to participate in the Community Service Obligation (CSO). Sigma Healthcare, Symbion, Australian Pharmaceutical Industries (API) and NPD (National Pharmacies) – have all been reappointed with new contracts that commenced …

Read More »

API to buy out Sigma

Australian Pharmaceutical Industries Limited (API) acquires 100 per cent of the shares in Sigma, via a scheme of arrangement (scheme). Under that proposal Sigma’s shareholders would receive 0.31 API shares and $0.23 cash for each Sigma share. Based on the terms of the API proposal and the API share price …

Read More »